New Medicines in Development for Cancer, Part 3

doi: 10.1097/01.COT.0000291007.70576.1c
Article

Part 3 of the latest Pharmaceutical Research and Manufacturers of America survey showing the 395 cancer-related medicines in the pipeline.

This table (Parts 1 and 2 appeared in the September issues) is adapted and excerpted from the latest Pharmaceutical Research and Manufacturers of America survey of New Medicines in Development for Cancer. As of the time of the report in May, there were 395 cancer-related medicines in the pipeline, with research being conducted by 181 companies as well as the NCI. Shown for each item are the name of the product, the company/organization involved, the cancer indication, the development status, and a contact telephone number when available to request further information.

Table. No caption av...
Table. No caption av...
Table. No caption av...
Table. No caption av...
Table. No caption av...
Table. No caption av...
© 2003 Lippincott Williams & Wilkins, Inc.
Home  Clinical Resource Center
Current Issue       Search OT
Archives Get OT Enews
Blogs Email us!